Calithera Biosciences, Inc. Gains 75%
Thu, Jul 11, 2024 at 07:22 PM
Calithera Biosciences, Inc. (CALA:NASDAQ) jumped higher at $0.04, a gain of 75%. On Thu, Jul 11, 2024, CALA:NASDAQ touched a New 2-Week High of $0.04. From Thu, Jun 27, 2024, the stock recorded 25.00% Up Days and 22.22% Green Days
About Calithera Biosciences, Inc. (CALA:NASDAQ)
Calithera Biosciences Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel small molecule drugs directed against tumor metabolism and tumor immunology targets for the treatment of cancer.
Top 10 Gainers:
- Locafy Limited (LCFY:NASDAQ), 158.47%
- Kazia Therapeutics Limited (KZIA:NASDAQ), 85.57%
- Cyngn Inc. (CYN:NASDAQ), 85.1%
- Calithera Biosciences, Inc. (CALA:NASDAQ), 75%
- NexImmune Inc. (NEXI:NASDAQ), 68.67%
- Biodexa Pharmaceuticals plc Sponsored ADR (New) 2023 (BDRX:NASDAQ), 51.88%
- Methode Electronics, Inc. (MEI:NYSE), 45.76%
- Bite Acquisition Corp. (BITE:NYSEMKT), 43.68%
- Bite Acquisition Corp. (BITE:NYSE), 43.68%
- Sonoma Pharmaceuticals, Inc. (SNOA:NASDAQ), 38.04%